Hims Review
✓ Updated July 2026
By the TelehealthIndex Editorial Team · How we score Not Recommended · #8 in Men's Health (ED & TRT)
By the TelehealthIndex Editorial Team · Advertising Disclosure: TelehealthIndex is reader-supported. If you sign up with a
provider through links on this page, we may earn a commission at no extra cost to you.
Commissions never influence our scores or rankings — several of our top-rated providers pay
us nothing. How we score → · Full disclosure →
Caution: unresolved FDA warning letter. This provider stays at its computed rank; its score is capped under
our methodology and it is not recommended while the matter is open.
47.3/100
Hims score
Not Recommended · #8 in Men's Health (ED & TRT) · Data as of July 2026
Clinical credibilityWeak
Regulatory & safety recordSerious deductions
Transparency & trustGood
Access & coverageMixed
Customer experienceGood
Value & pricingGood
Pillar ratings are qualitative summaries of our internal rubric; we do not publish the
point weights. Read the full methodology →
TelehealthIndex scores and rankings are editorial opinions resulting from our selection, weighting, and interpretation of the factors described in our methodology.
What it is
Category revenue leader: ED, hair, weight, TRT; own 503A/503B pharmacies; mid-transition from compounded to brand GLP-1s under Mar 2026 Novo deal.
Strengths
- Available nationwide (50 states)
- Lower-cost pricing for the category
Considerations
- CONFIRMED FDA warning letter Sept 2025 (compounded semaglutide equivalency claims); no closeout letter found - Caution gate applies
- Novo Nordisk terminated first partnership June 2025 citing deceptive marketing (renewed Mar 2026)
- Securities class actions pending; reported FTC probe of ads/cancellation
- Compounded chewable ED meds and enclomiphene are not FDA-approved
Note: this provider offers compounded medications for one or more services.
Compounded medications are not FDA-approved.
Founded2017
OwnershipPublic (NYSE: HIMS)
AvailabilityNationwide (50 states)
InsuranceNo
Money-back guaranteeNot advertised
PricingED generics from $22/mo; hair from $22/mo; weight formerly $199/mo compounded, brand pricing in transition
Visit Hims
We may earn a commission — disclosure.
Alternatives to consider
Sources
Every regulatory claim on this page is cited to its primary source (or the issuing agency's database). Verified against the cited document; see our Editorial Policy.
Data as of July 19, 2026. Scores are editorial opinions reflecting documented business practices, transparency, pricing, access, and nonclinical consumer-service factors — not clinical quality or outcomes. Found an error? Report it →